comparemela.com

Latest Breaking News On - Jennifer good - Page 4 : comparemela.com

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Trevi Therapeutics’ Q1 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

United-states
American
Annabel-samimy
Tom-smith
Serge-belanger
Sean-kim
Mayank-mamtani
Lisa-delfini
Nasdaq
American-thoracic-society
Trevi-therapeutics-inc
Drug-enforcement-agency

Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral.

United-states
American
Katie-mcmanus
Rosalia-scampoli
Exchange-commission
Company-on-twitter
Enforcement-agency
American-thoracic-society
Trevi-therapeutics-inc
Nasdaq
Linkedin
International-conference

vimarsana © 2020. All Rights Reserved.